| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4272639 | The Journal of Sexual Medicine | 2009 | 12 Pages |
Abstract
Successful identification of biomarkers and novel genes underlying FSD should improve the diagnosis, identification, and treatment of different subgroups. Future pharmacotherapeutic approaches to FSD will benefit from novel targets and the concept that individual variations have a genetic component may help destigmatize our views of sexual problems. Burri AV, Cherkas LM, and Spector TD. The genetics and epidemiology of female sexual dysfunction (FSD): A review. J Sex Med 2009;6:646-657.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Andrea V. MSc, Lynn M. PhD, Tim D. MD,